ConductScience.org, home

Comparison · NCT02512276-2e1d314e

Telepharmacist Intervention vs Usual Care: Healthcare Utilization - Hospitalizations

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Telepharmacist Intervention vs Usual Care: Healthcare Utilization - Hospitalizations. Trial comparisons, record NCT02512276-2e1d314e. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02512276-2e1d314e

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.08340.07220.0962wilson
Risk in group 20.07650.06570.0888wilson
Risk difference, group 1 minus group 20.00694-0.009750.0237newcombe hybrid score
Risk ratio, group 1 over group 21.090.8861.34log
Odds ratio, group 1 over group 21.10.8761.38log
Number needed to treat, for one more participant with the outcome on Telepharmacist Intervention than on Usual Care144from the risk difference intervalthe interval includes no difference

Groups2

Group 2 names the comparator: usual care.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Telepharmacist Intervention
Patients diagnosed with diabetes, hypertension, or hyperlipidemia exhibiting sub-optimal adherence to their medications \[defined as combined (average of averages) proportion of days covered (PDC) \< 80%\] who also have poor or worsening disease control.~Telepharmacist intervention: The intervention consists of a brief telephonic consultation with a clinical pharmacist using behavioral interviewing techniques tailored to patient's level of health activation and progress reports of medication-taking and disease control. Based on the barriers identified during the initial telephone consultation, patients will be offered more intensive support including reminder and motivational text-messages, video visits and pillboxes.
1702,038OG000
Group 2Usual CarePatients randomized to this arm will receive usual care.1562,040OG001

Outcome

Type
SECONDARY
Title
Healthcare Utilization - Hospitalizations
Description
Number of patients with at least 1 hospitalization.
Time frame
12 months
Population

Source ClinicalTrials.gov

Trial

Title
Tele-Pharmacy Intervention to Improve Treatment Adherence
NCT number
NCT02512276
Phases
NA
Conditions
Hyperlipidemia, Diabetes, Hypertension
Interventions
Telepharmacist intervention
Lead sponsor
Brigham and Women's Hospital
Results first posted
2019-06-06

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT02512276-2e1d314e